-
摘要: 乳房再造是乳腺癌患者综合治疗中重要的组成部分。近些年，以脱细胞真皮基质（acellular dermal matrix，ADM）为代表的补片在乳房再造中的临床应用，是该领域内最重要的创新。假体乳房再造中的补片广泛应用，促进即刻假体再造术的开展，提高乳房再造的美学效果，避免额外供区组织损害，因此被临床医生及患者广泛接受。乳房再造中常用补片主要有ADM、牛心包补片及TiLOOP补片，这些补片具有良好的组织相容性及缺损修补能力。本文将对此三种补片的应用及研究现状进行综述。Abstract: Breast reconstruction is an essential part in the comprehensive management of breast cancer. The clinical application of patches (e.g., acellular dermal matrix, ADM) is the most impactful innovation in implant breast reconstruction in recent years. The wide application of patches in implant breast reconstruction promotes the development of immediate prosthetic reconstruction, improves the aesthetic outcomes of reconstructed breasts, and avoids additional donor tissue damage caused by autologous flap breast reconstruction. At present, patches used in breast reconstruction are mainly ADMs, bovine pericardial patches, and TiLOOP, which are widely used because of their good histocompatibility and tissue defect repair ability. This article reviews the applications and research statuses of these patches.
-
Key words:
- breast reconstruction /
- acellular dermal matrix (ADM) /
- bovine pericardial patch /
- TiLOOP
-
表 1 不同类型补片的特点
-
[1] Frey JD, Salibian AA, Karp NS, et al. Implant- based breast reconstruction: hot topics, controversies, and new directions[J]. Plast Reconstr Surg, 2019, 143(2):404e-416e. https://journals.lww.com/plasreconsurg/Abstract/2019/02000/Implant_Based_Breast_Reconstruction__Hot_Topics,.53.aspx [2] Potter S, Conroy EJ, Cutress RI, et al. Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study[J]. Lancet Oncol, 2019, 20(2):254-266. doi: 10.1016/S1470-2045(18)30781-2 [3] Freeman MD, Vemula R, Rao R, et al. Refinements in the techniques of 2-stage breast reconstruction[J]. Ann Plast Surg, 2016, 76 (Suppl 4): S304-311. http://cn.bing.com/academic/profile?id=bf3c376d95c98c55a8a90d26e0ed1d5a&encoded=0&v=paper_preview&mkt=zh-cn [4] Qureshi AA, Broderick KP, Belz J, et al. Uneventful versus successful reconstruction and outcome pathways in implant- based breast reconstruction with acellular dermal matrices[J]. Plast Reconstr Surg, 2016, 138(2):173e-183e. http://cn.bing.com/academic/profile?id=e7df6b64035fc0ed83a3c374756273ae&encoded=0&v=paper_preview&mkt=zh-cn [5] Remington AC, Gurtner GC, Wan DC, et al. Identifying risk factors for postoperative major complications in staged implant-based breast reconstruction with AlloDerm[J]. Breast J, 2019[Epub ahead of print]. [6] Ricci JA, Treiser MD, Tao R, et al. Predictors of complications and comparison of outcomes using Surgimend fetal bovine and AlloDerm human cadaveric acellular dermal matrices in implant-based breast reconstruction[J]. Plast Reconstr Surg, 2016, 138(4):583e-591e. http://cn.bing.com/academic/profile?id=4df5716fd4fa16b467db9739f22c5ab7&encoded=0&v=paper_preview&mkt=zh-cn [7] Ibrahim AM, Koolen PG, Ganor O, et al. Does acellular dermal matrix really improve aesthetic outcome in tissue expander/implant-based breast reconstruction[J]? Aesthetic Plast Surg, 2015, 39(3):359-368. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=d1ab8d55058e629412c9dca3f10b217b [8] Yu D, Hanna KR, LeGallo RD, et al. Comparison of histological characteristics of acellular dermal matrix capsules to surrounding breast capsules in acellular dermal matrix-assisted breast reconstruction[J]. Ann Plast Surg, 2016, 76(5):485-488. doi: 10.1097/SAP.0000000000000368 [9] Jordan SW, Khavanin N, Kim JY. Seroma in prosthetic breast reconstruction[J]. Plast Reconstr Surg, 2016, 137(4):1104-1116. doi: 10.1097/01.prs.0000481102.24444.72 [10] Dikmans RE, Negenborn VL, Bouman MB, et al. Two-stage implantbased breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open- label, phase 4, multicentre, randomised, controlled trial[J]. Lancet Oncol, 2017, 18(2):251-258. doi: 10.1016/S1470-2045(16)30668-4 [11] Negenborn VL, Young-Afat DA, Dikmans REG, et al. Quality of life and patient satisfaction after one- stage implant- based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial[J]. Lancet Oncol, 2018, 19(9):1205-1214. doi: 10.1016/S1470-2045(18)30378-4 [12] Negenborn VL, Smit JM, Dikmans REG, et al. Short-term cost- effectiveness of one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage expander-implant reconstruction from a multicentre randomized clinical trial[J]. Br J Surg, 2019, 106(5):586-595. doi: 10.1002/bjs.2019.106.issue-5 [13] Schlenker JD, Bueno RA, Ricketson G, et al. Loss of silicone implants after subcutaneous mastectomy and reconstruction[J]. Plast Reconstr Surg, 1978, 62(6): 853-861. doi: 10.1097/00006534-197812000-00004 [14] Wagner RD, Braun TL, Zhu H, et al. A systematic review of complications in prepectoral breast reconstruction[J]. J Plast Reconstr Aesthet Surg, 2019[Epub ahead of print]. [15] Mofid MM, Meininger MS, Lacey MS. Veritas® bovine pericardium for immediate breast reconstruction: a xenograft alternative to acellular dermal matrix products[J]. Eur J Plast Surg, 2012, 35(10):717- 722. doi: 10.1007/s00238-012-0736-9 [16] Dawson A, Ramsay G, McKay C, et al. Immediate implant-based breast reconstruction using bovine pericardium (Veritas®) for optimal tissue regeneration[J]. Ann R Coll Surg Engl, 2013, 95(3):222. https://www.ncbi.nlm.nih.gov/pubmed/23827297 [17] Gubitosi A, Docimo G, Parmeggiani D, et al. Acellular bovine pericardium dermal matrix in immediate breast reconstruction after skin sparing mastectomy[J]. Int J Surg, 2014, 12 (Suppl 1):S205-208. http://cn.bing.com/academic/profile?id=308c9cc025ecea1450641b7c5f8f1497&encoded=0&v=paper_preview&mkt=zh-cn [18] Eichler C, Efremova J, Brunnert K, et al. A head to head comparison between SurgiMend®- fetal bovine acellular dermal Matrix and Tutomesh® - a bovine pericardium collagen membrane in breast reconstruction in 45 cases[J]. In Vivo, 2017, 31(4):677-682. doi: 10.21873/invivo [19] Dieterich M, Stubert J, Gerber B, et al. Biocompatibility, cell growth and clinical relevance of synthetic meshes and biological matrixes for internal support in implant- based breast reconstruction[J]. Arch Gynecol Obstet, 2015, 291(6):1371-1379. doi: 10.1007/s00404-014-3578-9 [20] Dieterich M, Angres J, Stachs A, et al. Patient-report satisfaction and health-related quality of life in TiLOOP® Bra-assisted or implant-based breast reconstruction alone[J]. Aesthetic Plast Surg, 2015, 39(4):523- 533. doi: 10.1007/s00266-015-0520-x [21] Casella D, Di Taranto G, Marcasciano M, et al. Evaluation of prepectoral implant placement and complete coverage with TiLoop Bra mesh for breast reconstruction: a prospective study on long-term and patient-reported BREAST-Q outcomes[J]. Plast Reconstr Surg, 2019, 143(1):1e- 9e. https://journals.lww.com/plasreconsurg/Abstract/2019/01000/Evaluation_of_Prepectoral_Implant_Placement_and.3.aspx [22] Casella D, Di Taranto G, Marcasciano M, et al. Subcutaneous expanders and synthetic mesh for breast reconstruction: long-term and patient-reported BREAST-Q outcomes of a single-center prospective study[J]. J Plast Reconstr Aesthet Surg, 2019, 72(5):805-812. doi: 10.1016/j.bjps.2018.12.018 [23] Eichler C, Schulz C, Thangarajah F, et al. A retrospective head-to-head comparison between TiLoop Bra/TiMesh® and Seragyn®in 320 cases of reconstructive breast surgery[J]. Anticancer Res, 2019, 39(5):2599- 2605. doi: 10.21873/anticanres.13383 [24] Riggio E, Chifu C, Martelli G, et al. Can titanium mesh influence local recurrence management after implant-based breast reconstruction [J]? Springerplus, 2015, 4:482. doi: 10.1186/s40064-015-1273-3 -
点击查看大图
表(1)
计量
- 文章访问数: 127
- HTML全文浏览量: 13
- PDF下载量: 14
- 被引次数: 0
下载:
